Sialic acids on varicella-zoster virus glycoprotein B are required for cell-cell fusion

Journal of Biological Chemistry

Volumn 290, Issue 32, 2015, Pages 19833-19843

  Suenaga, Tadahiro ^a,b   Matsumoto, Maki ^a,b   Arisawa, Fuminori ^a   Kohyama, Masako ^a,b   Hirayasu, Kouyuki ^a,b   Mori, Yasuko ^c   Arase, Hisashi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BUILDING MATERIALS; CARBOXYLIC ACIDS; CELL MEMBRANES; GLYCOPROTEINS; GLYCOSYLATION; LIGANDS; NEURONS; VIRUSES;

ASPARAGINE RESIDUE; CELL-CELL FUSION; CELLULAR MEMBRANES; N-GLYCOSYLATION; N-GLYCOSYLATION SITES; O-GLYCOSYLATION; POINT MUTATIONS; VARICELLA ZOSTER VIRUS;

CYTOLOGY;

ASPARAGINE; GLYCAN; GLYCOPROTEIN B; MYELIN ASSOCIATED GLYCOPROTEIN; SIALIC ACID; SIALIDASE; GLYCOPROTEIN B, VARICELLA-ZOSTER VIRUS; MAG PROTEIN, HUMAN; POLYSACCHARIDE; RECOMBINANT PROTEIN; SIALIC ACID DERIVATIVE; VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING SITE; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; HERPES ZOSTER; HUMAN; HUMAN CELL; MEMBRANE FUSION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; VARICELLA ZOSTER VIRUS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; CHEMISTRY; EPITHELIUM CELL; GENETICS; GLIA; GLYCOSYLATION; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; METABOLISM; PATHOLOGY; TUMOR CELL LINE; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

CELL LINE, TUMOR; EPITHELIAL CELLS; GLYCOSYLATION; HEK293 CELLS; HERPESVIRUS 3, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE FUSION; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURAMINIDASE; NEUROGLIA; POINT MUTATION; POLYSACCHARIDES; RECOMBINANT PROTEINS; SIALIC ACIDS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84939141991     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.635508     Document Type: Article

References (64)

1. Arvin, A. M. (2001) Varicella-zoster virus: molecular virology and virushost interactions. Curr. Opin. Microbiol. 4, 442-449
2. Cohen, J. I., Straus, S. E., and Arvin, A. M. (2006) Varicella-zoster virus: replication, pathogenesis, and management. in Fields VIROLOGY, 5th Ed., Vol. 2, pp. 2773-2818, Lippincott Williams & Wilkins, Philadelphia, PA
3. Zerboni, L., Sen, N., Oliver, S. L., and Arvin, A. M. (2014) Molecular mechanisms of varicella zoster virus pathogenesis. Nat. Rev. Microbiol. 12, 197-210
4. Steiner, I., Kennedy, P. G., and Pachner, A. R. (2007) The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 6, 1015-1028
5. Connolly, S. A., Jackson, J. O., Jardetzky, T. S., and Longnecker, R. (2011) Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat. Rev. Microbiol. 9, 369-381
6. Sedý, J. R., Spear, P. G., and Ware, C. F. (2008) Cross-regulation between herpesviruses and the TNF superfamily members. Nat. Rev. Immunol. 8, 861-873
7. Smith, A. E., and Helenius, A. (2004) How viruses enter animal cells. Science 304, 237-242
8. Marsh, M., and Helenius, A. (2006) Virus entry: open sesame. Cell 124, 729-740
9. Steven, A. C., and Spear, P. G. (2006) Biochemistry: viral glycoproteins and an evolutionary conundrum. Science 313, 177-178
10. Suenaga, T., Satoh, T., Somboonthum, P., Kawaguchi, Y., Mori, Y., and Arase, H. (2010) Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc. Natl. Acad. Sci. U.S.A. 107, 866-871
11. Varki, A., and Angata, T. (2006) Siglecs: the major subfamily of I-type lectins. Glycobiology 16, 1R-27R
12. Crocker, P. R., Paulson, J. C., and Varki, A. (2007) Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255-266
13. Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, K., Nikulina, E., Kimura, N., Cai, H., Deng, K., Gao, Y., He, Z., and Filbin, M. (2002) Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35, 283-290
14. Liu, B. P., Fournier, A., GrandPré, T., and Strittmatter, S. M. (2002) Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297, 1190-1193
15. Wörter, V., Schweigreiter, R., Kinzel, B., Mueller, M., Barske, C., Böck, G., Frentzel, S., and Bandtlow, C. E. (2009) Inhibitory activity of myelin-associated glycoprotein on sensory neurons is largely independent of NgR1 and NgR2 and resides within Ig-like domains 4 and 5. PLoS ONE 4, e5218
16. Venkatesh, K., Chivatakarn, O., Lee, H., Joshi, P. S., Kantor, D. B., Newman, B. A., Mage, R., Rader, C., and Giger, R. J. (2005) The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci. 25, 808-822
17. Atwal, J. K., Pinkston-Gosse, J., Syken, J., Stawicki, S., Wu, Y., Shatz, C., and Tessier-Lavigne, M. (2008) PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322, 967-970
18. Goh, E. L., Young, J. K., Kuwako, K., Tessier-Lavigne, M., He, Z., Griffin, J. W., and Ming, G. L. (2008) β1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones. Mol. Brain 1, 10
19. Strenge, K., Brossmer, R., Ihrig, P., Schauer, R., and Kelm, S. (2001) Fibronectin is a binding partner for the myelin-associated glycoprotein (siglec-4a). FEBS Lett. 499, 262-267
20. Vinson, M., Strijbos, P. J., Rowles, A., Facci, L., Moore, S. E., Simmons, D. L., and Walsh, F. S. (2001) Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J. Biol. Chem. 276, 20280-20285
21. Vyas, A. A., Patel, H. V., Fromholt, S. E., Heffer-Lauc, M., Vyas, K. A., Dang, J., Schachner, M., and Schnaar, R. L. (2002) Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc. Natl. Acad. Sci. U.S.A. 99, 8412-8417
22. Quarles, R. H. (2009) A hypothesis about the relationship of myelin-associated glycoprotein's function in myelinated axons to its capacity to inhibit neurite outgrowth. Neurochem. Res. 34, 79-86
23. Schnaar, R. L. (2010) Brain gangliosides in axon-myelin stability and axon regeneration. FEBS Lett. 584, 1741-1747
24. Vigerust, D. J., and Shepherd, V. L. (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 15, 211-218
25. Teuton, J. R., and Brandt, C. R. (2007) Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells. J. Virol. 81, 3731-3739
26. Wang, J., Fan, Q., Satoh, T., Arii, J., Lanier, L. L., Spear, P. G., Kawaguchi, Y., and Arase, H. (2009) Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor α depends on specific sialylated O-linked glycans on gB. J. Virol. 83, 13042-13045
27. Berarducci, B., Rajamani, J., Reichelt, M., Sommer, M., Zerboni, L., and Arvin, A. M. (2009) Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry. J. Virol. 83, 228-240
28. Litwin, V., Jackson, W., and Grose, C. (1992) Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J. Virol. 66, 3643-3651
29. Montalvo, E. A., and Grose, C. (1987) Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). J. Virol. 61, 2877-2884
30. Montalvo, E. A., Parmley, R. T., and Grose, C. (1985) Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J. Virol. 53, 761-770
31. Shiraki, K., Sato, H., Yamamura, J., Li, Z. H., Yokoyama, T., Hasegawa, T., Okuno, T., Kurokawa, M., and Kageyama, S. (1997) Functions of purified gB, gE:gI, and gH:gL, and their sialyl residues in varicella-zoster virus infection. Arch. Virol. 142, 2295-2301
32. Matsui, S., Okuno, T., and Shiraki, K. (1994) Functional roles of terminal glycomoieties in varicella-zoster virus infection. Virology 198, 50-58
33. Haan, K. M., Lee, S. K., and Longnecker, R. (2001) Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion. Virology 290, 106-114
34. Pertel, P. E. (2002) Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J. Virol. 76, 4390-4400
35. Tanaka, Y., Suenaga, T., Matsumoto, M., Seya, T., and Arase, H. (2013) Herpesvirus 6 glycoproteins B (gB), gH, gL, and gQ are necessary and sufficient for cell-to-cell fusion. J. Virol. 87, 10900-10903
36. Turner, A., Bruun, B., Minson, T., and Browne, H. (1998) Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J. Virol. 72, 873-875
37. Vanarsdall, A. L., Ryckman, B. J., Chase, M. C., and Johnson, D. C. (2008) Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J. Virol. 82, 11837-11850
38. Zerboni, L., Sommer, M., Ware, C. F., and Arvin, A. M. (2000) Varicellazoster virus infection of a human CD4-positive T-cell line. Virology 270, 278-285
39. Shiratori, I., Yamaguchi, M., Suzukawa, M., Yamamoto, K., Lanier, L. L., Saito, T., and Arase, H. (2005) Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J. Immunol. 175, 4441-4449
40. Nosaka, T., Kawashima, T., Misawa, K., Ikuta, K., Mui, A. L., and Kitamura, T. (1999) Stat5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18, 4754-4765
41. Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T., and Kumagai, H. (2003) Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31, 1007-1014
42. Okuma, K., Nakamura, M., Nakano, S., Niho, Y., and Matsuura, Y. (1999) Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay. Virology 254, 235-244
43. Paulson, J. C., Macauley, M. S., and Kawasaki, N. (2012) Siglecs as sensors of self in innate and adaptive immune responses. Ann. N.Y. Acad. Sci. 1253, 37-48
44. Kuroki, K., Wang, J., Ose, T., Yamaguchi, M., Tabata, S., Maita, N., Nakamura, S., Kajikawa, M., Kogure, A., Satoh, T., Arase, H., and Maenaka, K. (2014) Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILRα. Proc. Natl. Acad. Sci. U.S.A. 111, 8877-8882
45. Laughlin, S. T., and Bertozzi, C. R. (2007) Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation. Nat. Protoc. 2, 2930-2944
46. Prescher, J. A., and Bertozzi, C. R. (2006) Chemical technologies for probing glycans. Cell 126, 851-854
47. Alphey, M. S., Attrill, H., Crocker, P. R., and van Aalten, D. M. (2003) High resolution crystal structures of Siglec-7: insights into ligand specificity in the Siglec family. J. Biol. Chem. 278, 3372-3377
48. Attrill, H., Imamura, A., Sharma, R. S., Kiso, M., Crocker, P. R., and van Aalten, D. M. (2006) Siglec-7 undergoes a major conformational change when complexed with the α(2,8)-disialylganglioside GT1b. J. Biol. Chem. 281, 32774-32783
49. Attrill, H., Takazawa, H., Witt, S., Kelm, S., Isecke, R., Brossmer, R., Ando, T., Ishida, H., Kiso, M., Crocker, P. R., and van Aalten, D. M. (2006) The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design. Biochem. J. 397, 271-278
50. Bukrinsky, J. T., St Hilaire, P. M., Meldal, M., Crocker, P. R., and Henriksen, A. (2004) Complex of sialoadhesin with a glycopeptide ligand. Biochim. Biophys. Acta 1702, 173-179
51. Dimasi, N., Moretta, L., Biassoni, R., and Mariuzza, R. A. (2003) Expression, crystallization and preliminary crystallographic analysis of the extracellular IgV-like domain of the human natural killer cell inhibitory receptor p75/AIRM1. Acta Crystallogr. D Biol. Crystallogr. 59, 1856-1858
52. Zaccai, N. R., Maenaka, K., Maenaka, T., Crocker, P. R., Brossmer, R., Kelm, S., and Jones, E. Y. (2003) Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Structure 11, 557-567
53. Zaccai, N. R., May, A. P., Robinson, R. C., Burtnick, L. D., Crocker, P. R., Brossmer, R., Kelm, S., and Jones, E. Y. (2007) Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin. J. Mol. Biol. 365, 1469-1479
54. Zhuravleva, M. A., Trandem, K., and Sun, P. D. (2008) Structural implications of Siglec-5-mediated sialoglycan recognition. J. Mol. Biol. 375, 437-447
55. Kelm, S., Pelz, A., Schauer, R., Filbin, M. T., Tang, S., de Bellard, M. E., Schnaar, R. L., Mahoney, J. A., Hartnell, A., and Bradfield, P. (1994) Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 4, 965-972
56. Strenge, K., Schauer, R., Bovin, N., Hasegawa, A., Ishida, H., Kiso, M., and Kelm, S. (1998) Glycan specificity of myelin-associated glycoprotein and sialoadhesin deduced from interactions with synthetic oligosaccharides. Eur. J. Biochem. 258, 677-685
57. Strenge, K., Schauer, R., and Kelm, S. (1999) Binding partners for the myelin-associated glycoprotein of N2A neuroblastoma cells. FEBS Lett. 444, 59-64
58. Stanley, P., Schachter, H., and Taniguchi, N. (2009) Essentials of Glycobiology (Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., and Etzler, M. E., eds), 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
59. An, H. J., Froehlich, J. W., and Lebrilla, C. B. (2009) Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr. Opin. Chem. Biol. 13, 421-426
60. Sareneva, T., Mørtz, E., Tölö, H., Roepstorff, P., and Julkunen, I. (1996) Biosynthesis and N-glycosylation of human interferon-γ: Asn25 and Asn97 differ markedly in how efficiently they are glycosylated and in their oligosaccharide composition. Eur. J. Biochem. 242, 191-200
61. Sutton, C. W., O'Neill, J. A., and Cottrell, J. S. (1994) Site-specific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry. Anal. Biochem. 218, 34-46
62. Oliver, S. L., Sommer, M., Zerboni, L., Rajamani, J., Grose, C., and Arvin, A. M. (2009) Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. J. Virol. 83, 7495-7506
63. Gerken, T. A. (2012) O-glycoprotein biosynthesis: site localization by Edman degradation and site prediction based on random peptide substrates. Methods Mol. Biol. 842, 81-108
64. Ten Hagen, K. G., Fritz, T. A., and Tabak, L. A. (2003) All in the family: the UDP-GalNac:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13, 1R-16R